FMC (FMC) Wells Fargo 2024 Industrials Conference summary
Event summary combining transcript, slides, and related documents.
Wells Fargo 2024 Industrials Conference summary
1 Feb, 2026Leadership transition and management update
Pierre Brondeau returns as CEO and chairman, replacing Mark Douglas, ensuring a smooth transition due to his deep familiarity with the business.
Mark Douglas will remain as a senior advisor through September to support the transition.
The leadership change was a mutual decision between the board and Mark Douglas.
Financial guidance and market outlook
Second quarter revenue and EBITDA guidance reaffirmed, with EBITDA expected between $170–$210 million.
Full-year guidance not confirmed; more details to be provided in August as the new CEO reviews business specifics.
2024 is described as a transition year, moving from market correction to recovery, with anticipated growth despite volatility.
Q2 expected to show flattish to low-teens growth, reflecting ongoing volatility and market transition.
Industry and inventory dynamics
The crop protection industry experienced a major inventory correction over the past year, following overbuying during COVID-related disruptions.
Channel inventories are now rebalancing, with some regions experiencing inventory levels below historical norms.
Long-term demand for crop protection products remains strong, with a historical 3–4% compound annual growth rate.
Latest events from FMC
- Key governance, compensation, and shareholder rights reforms headline the 2026 annual meeting.FMC
Proxy Filing13 Mar 2026 - Key votes include director elections, say-on-pay, and expanded shareholder rights proposals.FMC
Proxy Filing13 Mar 2026 - Proxy seeks approval for director elections, governance reforms, and a new performance-based incentive plan.FMC
Proxy Filing3 Mar 2026 - Operational overhaul, asset sales, and licensing drive transformation amid strategic review.FMC
Bank of America 2026 Global Agriculture and Materials Conference26 Feb 2026 - 2025 losses deepen on price pressure and impairment; 2026 outlook cautious amid strategic review.FMC
Q4 20255 Feb 2026 - Recovery underway, new products and cost actions position for strong growth through 2025.FMC
Wolfe Research Materials of the Future Conference3 Feb 2026 - Q2 net income surged on tax benefit; full-year guidance trimmed, but H2 rebound expected.FMC
Q2 20242 Feb 2026 - New product launches and a shift to formulations drive growth as markets normalize.FMC
Jefferies Global Industrial Conference22 Jan 2026 - Q3 revenue up 9% to $1.07B; restructuring and GSS sale drive improved outlook.FMC
Q3 202417 Jan 2026